| scholarly article | Q13442814 |
| P50 | author | Michael Hanna | Q20876911 |
| John S Thornton | Q57050521 | ||
| Tarek A Yousry | Q58364812 | ||
| Jean-Yves Hogrel | Q58818465 | ||
| Volker Straub | Q59878147 | ||
| Julia R Dahlqvist | Q85559719 | ||
| Anna G Mayhew | Q90185542 | ||
| Pierre G Carlier | Q90591135 | ||
| Kieren G Hollingsworth | Q91380826 | ||
| Alexander Peter Murphy | Q92808178 | ||
| P2093 | author name string | Tanya Stojkovic | |
| Christopher D J Sinclair | |||
| John Vissing | |||
| Michelle Eagle | |||
| Jasper Morrow | |||
| Laurence E Lee | |||
| Meredith K James | |||
| Stephen Wastling | |||
| Tracey A Willis | |||
| P2860 | cites work | The timed "Up & Go": a test of basic functional mobility for frail elderly persons | Q29615553 |
| Upper Limb Evaluation in Duchenne Muscular Dystrophy: Fat-Water Quantification by MRI, Muscle Force and Function Define Endpoints for Clinical Trials | Q31131975 | ||
| Two-point Dixon technique for water-fat signal decomposition with B0 inhomogeneity correction | Q32175707 | ||
| Three-point Dixon technique for true water/fat decomposition with B0 inhomogeneity correction | Q33577161 | ||
| Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population | Q33685609 | ||
| ATS Statement | Q34136219 | ||
| Flow cytometry for the analysis of α-dystroglycan glycosylation in fibroblasts from patients with dystroglycanopathies | Q34873693 | ||
| Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study | Q34963315 | ||
| FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients | Q35445374 | ||
| Simple proton spectroscopic imaging | Q36586763 | ||
| Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort. | Q37114363 | ||
| The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study | Q37298079 | ||
| Reliability of the North Star Ambulatory Assessment in a multicentric setting. | Q37530045 | ||
| Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy | Q37577885 | ||
| Quantitative magnetic resonance imaging in limb-girdle muscular dystrophy 2I: a multinational cross-sectional study | Q37610370 | ||
| Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy. | Q39213123 | ||
| Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy. | Q39409381 | ||
| B4GALNT2 (GALGT2) Gene Therapy Reduces Skeletal Muscle Pathology in the FKRP P448L Mouse Model of Limb Girdle Muscular Dystrophy 2I. | Q39453819 | ||
| Muscle and heart function restoration in a limb girdle muscular dystrophy 2I (LGMD2I) mouse model by systemic FKRP gene delivery | Q40610977 | ||
| The phenotype of limb-girdle muscular dystrophy type 2I | Q44411539 | ||
| Subepicardial dysfunction leads to global left ventricular systolic impairment in patients with limb girdle muscular dystrophy 2I. | Q45384428 | ||
| The quality of life in genetic neuromuscular disease questionnaire: Rasch validation of the French version | Q47579115 | ||
| 216th ENMC international workshop: Clinical readiness in FKRP related myopathies January 15-17, 2016 Naarden, The Netherlands | Q48793388 | ||
| The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study. | Q50858360 | ||
| Contractile properties are disrupted in Becker muscular dystrophy, but not in limb girdle type 2I. | Q52673776 | ||
| Significant response to immune therapies in a case of subacute necrotizing myopathy and FKRP mutations. | Q53347402 | ||
| Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I | Q59697187 | ||
| The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus | Q69772148 | ||
| ACTIVLIM: a Rasch-built measure of activity limitations in children and adults with neuromuscular disorders | Q80157260 | ||
| Inflammation and response to steroid treatment in limb-girdle muscular dystrophy 2I | Q80186224 | ||
| Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study | Q80235144 | ||
| Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy | Q85398934 | ||
| Magnetic resonance imaging in Duchenne muscular dystrophy: longitudinal assessment of natural history over 18 months | Q86661606 | ||
| Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy | Q87419552 | ||
| 229th ENMC international workshop: Limb girdle muscular dystrophies - Nomenclature and reformed classification Naarden, the Netherlands, 17-19 March 2017 | Q90589536 | ||
| P433 | issue | 6 | |
| P921 | main subject | muscular dystrophy | Q1137767 |
| P304 | page(s) | 1033-1045 | |
| P577 | publication date | 2019-05-16 | |
| P1433 | published in | Annals of clinical and translational neurology | Q27725312 |
| P1476 | title | Natural history of limb girdle muscular dystrophy R9 over 6 years: searching for trial endpoints | |
| P478 | volume | 6 |
Search more.